ECFS 2020 - Optimizing pharmaceutical care in cystic fibrosis

116 OPTIMIZING PHARMACEUTICAL CARE IN CYSTIC FIBROSIS PARENTERAL ADMINISTRATION: CHALLENGES AND SOLUTIONS CHAPTER 6 [20] Salcedo A, Giron RM, Beltran B, Martinez A, Maiz L, Suarez L, et al. [Consensus conference: home intra- venous antibiotic treatment for cystic fibrosis. The Sira Carrasco Foundation. 26 April 2002]. Arch Bronconeumol. 2003;39(10):469-75. [21] Sequeiros IM, Jarad NA. Home intra- venous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient? Ann Thorac Med. 2009;4(3):111-4. [22] Goodfellow AF, Wai AO, Frighetto L, Marra CA, Ferreira BM, Chase ML, et al . Quality-of-life assessment in an outpatient parenteral antibi- otic program. Ann Pharmacother. 2002;36(12):1851-5. [23] Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J. Home intra- venous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit. Hippokratia. 2016;20(4):279-83. [13] Patel S, Abrahamson E, Goldring S, Green H, Wickens H, Laundy M. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360-73. [14] Collaco JM, Green DM, Cutting GR, Naughton KM, Mogayzel PJ, Jr. Location and duration of treatment of cystic fibrosis respiratory exac- erbations do not affect outcomes. Am J Respir Crit Care Med. 2010;182(9):1137-43. [15] Balaguer A, Gonzalez de Dios J. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev. 2015(12):CD001917. [16] Berrevoets MAH, Oerlemans AJM, Tromp M, Kullberg BJ, Ten Oever J, Schouten JA, et al. Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study. BMJ Open. 2018;8(11):e024564. [17] Home intravenous therapy Factsheet 2016 [cited 2019 October]. Available from: . [18] Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospec- tive randomized trial examining clin- ical, quality of life and cost aspects. Eur Respir J. 1997;10(4):896-900. [19] Home intravenous therapy Factsheet [cited 2016 July]. Available from: .